Manufacturing and Production

Showing 15 posts of 5871 posts found.

frank_armstrong_chairman

Uni spin out gets new chariman, CFO, COO

May 27, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Caldan Therapeutics is a spin-out company from the Universities of Glasgow and Southern Denmark which is looking at developing novel …
sanofi_hq__boetie_hall

Sanofi makes move to remove Medivation board; Medivation hits back

May 25, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medivation, Sanofi, removal of board, takeover

Sanofi (NYSE: SNY) has taken their proposed takeover of Medivation (NASDAQ: MDVN) up several notches, with the French company filing …
gilead-sciences

Gilead names Kevin Young new chief operating officer

May 25, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead

Gilead Sciences (NASDAQ: GILD) has announced two new senior appointments, including Kevin Young as its new chief operating officer. Martin …

Focus: Regulators Enter the Drug Pricing Debate

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, pharma industry, regulation

By Anjali Shukla The Chinese authorities have come down strongly on the issue of drug costs, slashing the prices of …
test_results

MOD to ban use of Roche anti-malaria drug, Lariam, for armed forces

May 24, 2016 Manufacturing and Production, Sales and Marketing anti-malaria drug, armed forces, lariam, mod

A parliamentary committee has published a new report urging the armed forces not to use anti-malaria drug, Lariam, due to …

Pfizer says EMA lifts warning on its smoking cessation drug Champix

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Champix, EMA, Pfizer, anti-smoking, drug trial

US pharma giant Pfizer (NYSE: PFE) said the European Medicines Agency has lifted a warning on its anti-smoking drug Champix …
needles

CSL’s flu vaccine scores FDA approval

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing CSL, FDA, Vaccine, flu, four strain, four-strain, influenza, influenza a, influenza b, seqirus

Seqirus, a division of CSL, has announced that the US Food and Drug Administration (FDA) has approved Flucelvax Quadrivalent (influenza …
ema_building_face_web

Sandoz biosimilar accepted for regulatory submission by EMA

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing EMA, Sandoz, biosimilar

Sandoz, a division of Novartis, has announced that the European Medicines Agency (EMA) has accepted its marketing authorisation application for …

US FDA advisors question usefulness of Sanofi’s combination diabetes therapy

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, US FDA, diabetes, drug trial, regulation

US Food and Drug Administration staff questioned the benefits of French drugmaker Sanofi’s (Euronext: SAN) diabetes drug candidate as well …
lab

French authorities pins blame on Bial and Biotrial for fatal drug trial

May 24, 2016 Manufacturing and Production, Research and Development Bial, Biotrial, France, blame, clinical trial, death, disaster, minister for health, report

Authorities in France have criticised the pharmaceutical company and the clinical research organisation at the centre of the Rennes clinical …
janssen_latest_logo_on_sign

Janssen’s Darzalex gets conditional European Commission approval to treat multiple myeloma

May 24, 2016 Manufacturing and Production, Research and Development, Sales and Marketing

Janssen said the European Commission (EC) conditionally approved its biologic Darzalex (daratumumab) to treat blood cancer.  The company said Daratumumab …
stocks1

Weekly Movers: Valeant, Anacor, Regeneron…

May 23, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Acorda, Aduro Biotech, Anacor Pharma, Financial, MacroGenics, Merck, Regeneron Pharma, Valeant Pharma

The earnings season came to a close with Germany’s Merck doubling its first-quarter profits. For the week, drug trials, analyst …
money_pills_2

Horizon to acquire worldwide rights to Boehringer Ingelheim genetic disease drug

May 20, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, actimmune, agreement, horizon, interferon gamma-1b, worldwide rights

Horizon Pharmaceuticals (NASDAQ: HZNP) has entered into a worldwide rights agreement with Boehringer Ingelheim to acquire interferon gamma-1b, which is …

Urgent action needed on antimicrobial resistance, says government report

May 19, 2016 Manufacturing and Production, Medical Communications, Research and Development ABPI, Lord Jim O'Neill, NICE, antimicrobial resistance

A new UK governmental report has warned that the global rise of antimicrobial resistance is set to worsen, with the …

Bayer makes bid for Monsanto

May 19, 2016 Manufacturing and Production, Sales and Marketing Bayer, agrochemical, bid, monsanto, takeover

Bayer (ETR: BAYN) has made a move to consolidate its position in the agrochemical sector with an unsolicited takeover bid …
The Gateway to Local Adoption Series

Latest content